StockWatch
·
HomeLiveReports

JENBURKT PHARMACEUTICALS LTD.

BSE: 524731

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-0.0717.1334.3251.51Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27

Margin Trend

percentage
OPM %NPM %
10.9017.6324.3631.09Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
PeriodQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
INCOME
Revenue35.51-20.4%44.63+3.7%43.02-5.6%45.56+28.2%35.53-13.4%41.05+11.3%36.89-10.5%41.22
Other Income1.51-65.2%4.35+139.6%1.81-12.7%2.08+1.1%2.06+9.4%1.88+18.8%1.58-14.6%1.85
Total Income37.03-24.4%48.98+9.2%44.84-5.9%47.64+26.7%37.58-12.4%42.93+11.6%38.48-10.7%43.07
EXPENSES
Expenditure30.26-3.4%31.32-14.3%36.54+9.7%33.30+21.5%27.40-11.9%31.09+7.4%28.96-5.2%30.55
Tax0.88-69.1%2.86+20.9%2.37-43.3%4.17+74.4%2.39-27.5%3.30+9.7%3.01+2.9%2.92
PROFIT
PBT6.77-50.6%13.71+65.2%8.30-42.1%14.33+40.8%10.18-14.0%11.84+24.4%9.51-24.0%12.52
Net Profit5.89-45.8%10.85+82.9%5.93-41.6%10.16+30.4%7.79-8.7%8.54+31.2%6.51-32.2%9.60
KEY METRICS
OPM %16.97%-6.10pp23.07%+5.80pp17.27%-11.49pp28.76%+3.55pp25.21%-1.24pp26.45%+7.36pp19.09%-4.97pp24.06%
NPM %15.90%-6.25pp22.15%+8.92pp13.23%-8.11pp21.34%+0.61pp20.73%+0.84pp19.89%+2.98pp16.91%-5.38pp22.29%
EPS13.34-45.7%24.58+82.9%13.44-41.6%23.03+30.4%17.66-8.7%19.34+31.1%14.75-32.2%21.75

Corporate Events

Board MeetingJENBURPH
2026
4Sep

Board Meeting

The 41st Annual General Meeting (AGM) will be held on Friday…

BSE Filing ↗
Board MeetingJENBURPH
2026
6Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingJENBURPH
2025
28Jan

Board Meeting

Approval of standalone unaudited financial results for the q…

BSE Filing ↗
Board MeetingJENBURPH
2024
5Nov

Board Meeting

Consider and approve Standalone unaudited financial results …

BSE Filing ↗
Board MeetingJENBURPH
2024
6Feb

Board Meeting

consider and approve the Standalone unaudited financial resu…

BSE Filing ↗
Board MeetingJENBURPH
2023
7Nov

Board Meeting

consider and approve unaudited financial results for the qua…

BSE Filing ↗